ARTICLE | Company News
EC approves Boehringer's Giotrif for NSCLC
September 26, 2013 1:11 AM UTC
The European Commission approved an MAA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Giotrif afatinib to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) with activat...